| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996717 | Practical Radiation Oncology | 2015 | 8 Pages |
Abstract
SBRT is both safe and effective for treating RCC bone metastases, with rapid improvement in symptoms after treatment and more durable clinical and radiographic response rate. Future prospective trials are needed to further define efficacy and toxicity of treatment, especially in the setting of targeted agents.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Arya MD, Basel BS, Maria T. MD, Edward PhD, Shilpa PhD, Elizabeth R. MD, Thomas W. MD, PhD, Christine M. MD, MPH, Brian D. MD, MPH, Elaine T. MD, Sana D. MD, PhD,